The Nassau Guardian1d
Chronic kidney disease projected to be 5th leading cause of death in five years
With chronic kidney disease projected to be the fifth leading cause of death by 2040, Nephrologist Dr. Adrian Sawyer is ...
Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock
BofA Securities, Evercore ISI, Goldman Sachs & Co. LLC, Stifel and Wells Fargo Securities are acting as joint book-running managers for the offering. LifeSci Capital is acting as lead manager and H.C.
Everyday Health5d
What Is Addison’s Disease?
Addison’s disease is a rare condition in which the adrenal glands do not produce enough of the hormones cortisol and ...
Rolling Out7d
What happens when your kidneys stop working?
Learn how failing kidneys cause dangerous fluid buildup, blood cell reduction, heart-threatening electrolyte imbalances, and ...
Mineralys Therapeutics Announces Proposed Public Offering of Common Stock
BofA Securities, Evercore ISI, Goldman Sachs & Co. LLC, Stifel and Wells Fargo Securities are acting as joint book-running managers for the offering. LifeSci Capital is acting as lead manager and H.C.
Mineralys Therapeutics' stock price explodes after lorundrostat study results
A Radnor biopharma firm saw its stock price skyrocket after the company posted positive late-stage clinical trial results for ...